A randomized phase III trial comparing sorafenib plus best supportive care (BSC) versus BSC alone in Child-Pugh B patients (pts) with advanced hepatocellular carcinoma (HCC): The BOOST study

被引：0
|
作者：
Daniele, Bruno
Di Maio, Massimo
Gallo, Ciro
Gasbarrini, Antonio
Carteni, Giacomo
Di Costanzo, Giovan Giuseppe
Craxi, Antonio
Cabibbo, Giuseppe
Bolondi, Luigi
Granito, Alessandro
Missale, Gabriele
Frassoldati, Antonio
Angelico, Mario
Roselli, Mario
Daniele, Gennaro
Perrone, Francesco
机构：
[1] G Rummo Hosp, Benevento, Italy
[2] Natl Canc Inst, Clin Trials Unit, Naples, Italy
[3] Univ Naples 2, Naples, Italy
[4] Policlin Univ Agostino Gemelli, Rome, Italy
[5] Azienda Osped Rilievo Nazl A Cardarelli, Naples, Italy
[6] Azienda Osped Univ, Policlin Paolo Giaccone, Palermo, Italy
[7] Azienda Osped Univ Policlin St Orsola Malpighi, Bologna, Italy
[8] Azienda Osped Univ Parma, Parma, Italy
[9] Az Osped Univ Arcispedale St Anna Ferrara, Ferrara, Italy
[10] Azienda Osped Univ Policlin Tor Vergata, Rome, Italy
[11] Natl Canc Inst, Naples, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4151
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Vinorelbine plus best supportive care (BSC) vs BSC in the treatment of advanced non small cell lung cancer (NSCLC) elderly patients (pts). Results of a phase III randomized trial
    Clerici, M
    Frontini, L
    Ianniello, GP
    Maiorino, L
    Piantedosi, FV
    Cigolari, S
    Manzione, L
    Failla, G
    Zuccarino, L
    Pedicini, T
    Vinante, O
    Castiglione, F
    Bearz, A
    Tonato, M
    Rossi, A
    Monfardini, S
    Gallo, C
    Perrone, F
    Gridelli, C
    ANNALS OF ONCOLOGY, 1998, 9 : 62 - 62
  • [12] Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care
    Stefanini, Benedetta
    Bucci, Laura
    Santi, Valentina
    Reggidori, Nicola
    Lani, Lorenzo
    Granito, Alessandro
    Pelizzaro, Filippo
    Cabibbo, Giuseppe
    Di Marco, Mariella
    Ghittoni, Giorgia
    Campani, Claudia
    Svegliati-Baroni, Gianluca
    Foschi, Francesco Giuseppe
    Giannini, Edoardo G.
    Biasini, Elisabetta
    Saitta, Carlo
    Magalotti, Donatella
    Sangiovanni, Angelo
    Guarino, Maria
    Gasbarrini, Antonio
    Rapaccini, Gian Ludovico
    Masotto, Alberto
    Sacco, Rodolfo
    Vidili, Gianpaolo
    Mega, Andrea
    Azzaroli, Francesco
    Nardone, Gerardo
    Brandi, Giovanni
    Sabbioni, Simone
    Vitale, Alessandro
    Trevisani, Franco
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (09) : 1582 - 1591
  • [13] Is sorafenib (S) safe and effective in patients (pts) with hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis?
    Abou-Alfa, G. K.
    Amadori, D.
    Santoro, A.
    Figer, A.
    De Greve, J.
    Lathia, C.
    Voliotis, D.
    Anderson, S.
    Moscovici, M.
    Ricci, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [14] Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC)
    Llovet, J.
    Ricci, S.
    Mazzaferro, V.
    Hilgard, P.
    Raoul, J.
    Zeuzem, S.
    Poulin-Costello, M.
    Moscovici, M.
    Voliotis, D.
    Bruix, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [15] Phase IIb randomized trial of Pexa-Vec (pexastimogene devacirepvec; JX-594), a targeted oncolytic vaccinia virus, plus best supportive care (BSC) versus BSC alone in patients with advanced hepatocellular carcinoma who have failed sorafenib treatment (TRAVERSE)
    Heo, Jeong
    Chao, Yee
    Jonker, Derek J.
    Baron, Ari David
    Habersetzer, Francois
    Burke, James
    Breitbach, Caroline
    Patt, Richard H.
    Lencioni, Riccardo
    Homerin, Michel
    Limacher, Jean-Marc
    Lusky, Monika
    Hickman, Theresa
    Longpre, Lara
    Kirn, David H.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [16] Phase 3, randomized KEYNOTE-240 study of pembrolizumab (Pembro) versus best supportive care (BSC) for second-line advanced hepatocellular carcinoma (HCC)
    Chan, S. L.
    Finn, R. S.
    Zhu, A. X.
    Knox, J.
    Cheng, A-L.
    Siegel, A. B.
    Bautista, O.
    Kudo, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [17] Vinorelbine (VNR) plus best supportive care (BSC) vs BSC in the treatment of advanced non-small cell lung cancer (NSCLC) elderly patients (Pts). Results of a phase III randomized trial
    Gridelli, C
    Ianniello, GP
    Maiorino, L
    Brancaccio, L
    Cigolari, S
    Bilancia, D
    Aiello, R
    Zuccarino, L
    Pedicini, T
    Zonato, S
    Pappagallo, GL
    Monfardini, S
    Rossi, A
    Gallo, C
    Perrone, F
    BRITISH JOURNAL OF CANCER, 1998, 78 : 3 - 3
  • [18] Vinorelbine(VNR) plus best supportive care (BSC) vs BSC in the treatment of advanced non-small cell lung cancer (NSCLC) elderly patients (pts). Results of a phase III randomized trial
    Gridelli, C
    Ianniello, GP
    Maiorino, L
    Piantedosi, V
    Cigolari, S
    Manzione, L
    Failla, G
    Zuccarino, L
    Pedicini, T
    Vinante, O
    Castiglione, F
    Clerici, M
    Bearz, A
    Darwish, S
    Rossi, A
    Monfardini, S
    Gallo, C
    Perrone, F
    Frontini, L
    ANNALS OF ONCOLOGY, 1998, 9 : 85 - 85
  • [19] A multicenter, randomized, double-blind, phase III study of ramucirumab (IMC-1121B; RAM) and best supportive care (BSC) versus placebo (PBO) and BSC as second-line treatment in patients (pts) with hepatocellular carcinoma (HCC) following first-line therapy with sorafenib (SOR)
    Zhu, Andrew X.
    Chau, Ian
    Blanc, Jean-Frederic
    Okusaka, Takuji
    Rojas, Maria
    Yang, Ling
    Von Broen, Ingo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [20] Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child–Pugh B cirrhosis
    Jean-Frédéric Blanc
    Faiza Khemissa
    Jean-Pierre Bronowicki
    Carole Monterymard
    Jean-Marc Perarnau
    Vincent Bourgeois
    Stéphane Obled
    Meher Ben Abdelghani
    Isabelle Mabile-Archambeaud
    Roger Faroux
    Jean-François Seitz
    Christophe Locher
    Hélène Senellart
    Anne-Laure Villing
    Franck Audemar
    Charlotte Costentin
    Gaël Deplanque
    Sylvain Manfredi
    Julien Edeline
    Hepatology International, 2021, 15 : 93 - 104
12345